Overview

Safety and Efficacy of Pyronaridine Artesunate Versus Chloroquine in Children and Adult Patients With Acute Plasmodium Vivax Malaria

Status:
Terminated

Trial end date:
2010-11-15

Target enrollment:

Participant gender:

Summary

The primary objective of this clinical study is to compare the efficacy and safety of the fixed combination of pyronaridine artesunate (180:60 mg) with that of standard chloroquine therapy in children and adults with acute, uncomplicated Plasmodium vivax (P. vivax) malaria

Phase:

Phase 3

Details

Lead Sponsor:

Medicines for Malaria Venture

Collaborator:

Shin Poong Pharmaceuticals

Treatments:

Artesunate
Chloroquine
Pyronaridine